TAGRISSO 40 mg Film-Coated 30 Tablet
28409.90ر.س
Out of Stock
Product description
Product description: Tajriso contains the active substance Osimertinib, which belongs to a group of medicines called protein kinase inhibitors, and they are used in cancer treatment. Tajriso is used to treat adults with a type of lung cancer called non-small cell lung cancer. If any test shows that your cancer has specific mutation changes in a gene called egfr, epidermal growth factor receptor, then your cancer is more likely to respond to treatment with Tajriso.
Tajriso can be prescribed to you: after complete removal of the cancer as adjuvant therapy or as the first medicine you receive for cancer that has spread to other parts of the body, or in certain cases if you have previously received other protein kinase inhibitors for cancer treatment.
Usage instructions: Take this medicine as always directed by your doctor or pharmacist. Consult your doctor or pharmacist if you are unsure of the correct way to take it.
The recommended dose is one 80 mg tablet daily. Your doctor may reduce your dose to one 40 mg tablet daily if necessary.
Tajriso is taken orally. Swallow the tablet whole with a little water. Avoid crushing, splitting, or chewing the tablet.
Take Tajriso every day at the same time.
You can take this medicine with or without food.
If you have difficulty swallowing the tablet, you can mix it with water: put the tablet in a cup.
Add about 50 ml of approximately two-thirds of still, non-carbonated water — do not use any other liquids.
Stir the water until the tablet breaks into very small pieces — it will not dissolve completely.
Drink the liquid immediately.
To ensure you take the entire dose, rinse the cup well with another 50 ml of water and drink it too.
Keep this medicine out of reach of children and their eyes.
Do not use this medicine after the expiration date printed on the strip and box. The expiration date indicates the last day of the month shown.
This medicine does not require special storage conditions.
Warnings and precautions: Talk to your doctor, pharmacist, or nurse before taking Tajriso in the following cases:
If you have a lung condition called "interstitial lung disease."
If you have ever had heart problems; your doctor may need to monitor you closely.
If you have a history of eye problems.
If any of the above applies to you or if you are unsure, speak to your doctor, pharmacist, or nurse before taking this medicine.
Tell your doctor immediately during treatment if you experience: sudden difficulty breathing with cough or fever.
If you experience severe skin peeling.
Tajriso has not been studied in children or adolescents.
Therefore, avoid giving this medicine to children or adolescents under 18 years old.
Ingredients: The active substance is Osimertinib in film-coated tablets. Each 40 mg tablet contains 40 mg of Osimertinib.
Other excipients: Mannitol, microcrystalline cellulose, hypromellose, sodium stearoyl fumarate, polyvinyl alcohol, titanium dioxide, macrogol 3350, talc, yellow iron oxide, red iron oxide, and iron oxide yellow.
Tajriso 40 mg is available in round, biconvex, beige-colored film-coated tablets, marked with "az" and "40" on one side, with no printing on the other side.
Product details:
Brand: Tajriso
Questions you might have

